SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS
申请人:AstraZeneca AB
公开号:EP1299381A1
公开(公告)日:2003-04-09
[EN] SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS<br/>[FR] DERIVES DE LA QUINAZOLINE SUBSTITUES ET LEUR UTILISATION COMME INHIBITEURS
申请人:ASTRAZENECA AB
公开号:WO2002000649A1
公开(公告)日:2002-01-03
The use of a compound of formula (I) or a salt, ester or amide thereof; where X is O, or S, S(O) or S(O)2, or NR6 where R6 is hydrogen or C¿1-6?alkyl; R?5¿ is an optionally substituted 5-membered heteroaromatic ring, R?1, R2, R3, R4¿ are independently selected from various specified moieties, in the preparation of a medicament for use in the inhibition of aurora 2 kinase. Certain compounds are novel and these, together with pharmaceutical compositions containing them are also described and claimed.